about
Ectonucleotidases in tumor cells and tumor-associated immune cells: an overviewAnti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target moleculeMicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73.Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma.The roles of CD73 in cancerNTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression.CD73-generated adenosine is critical for immune regulation during Toxoplasma gondii infection.Classification of current anticancer immunotherapiesEcto-5'-nucleotidase expression is associated with the progression of renal cell carcinoma.CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer.CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.Anti-CD73 in cancer immunotherapy: awakening new opportunities.CD39 and CD73 in immunity and inflammation.CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cellsUnraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche.Ectonucleotidase expression profile and activity in human cervical cancer cell lines.A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes.Crystallization and preliminary X-ray analysis of the open form of human ecto-5'-nucleotidase (CD73)CD73 as a novel marker for poor prognosis of oral squamous cell carcinoma.Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway.Adenosine Production by Biomaterial-Supported Mesenchymal Stromal Cells Reduces the Innate Inflammatory Response in Myocardial Ischemia/Reperfusion Injury.Ectonucleotidase inhibitors: a patent review (2011-2016).CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer.
P2860
Q27002950-A0F0819D-2140-41D7-9CAA-6ED3B2462ED9Q27015933-26F02357-EBE3-4E58-A885-3056434265B9Q33630440-1E1249F1-A3D2-4F92-9711-B7BD380D3710Q33771631-811D1943-5796-49D9-A624-816DD6D091A7Q34003164-E260D1EE-7867-4B45-83B3-7822C589240BQ34123241-92FFD2A4-5CE1-4CF1-9CEE-C62BE4E70917Q34955749-C075723C-566F-498C-82D1-BC9E4EA6E7EAQ35149637-833AC5F8-4B1C-4E90-9E5D-7FE0DD9321F5Q35758898-55EE30A1-78E6-45CA-A85C-A114A854008CQ36205304-DA9FC450-00D5-4522-A2B3-F78265DE67DBQ36281750-651918BE-B969-4A66-AF62-803047BD7DA0Q36709157-C0B9E3E3-6FFC-46BA-B497-885C1E2FDFBCQ36906658-C02206BC-933E-40A5-A6F0-1AE94CCD6163Q37151029-036F31A6-749D-4F4D-8B6E-1709712E7134Q38232436-0E3DB051-6EBF-401A-9C2A-47B0BAFEF2A8Q39008567-28DE2192-1E2B-402A-87B7-6FC6BC094C6CQ41983445-A336C76B-011A-4ED4-AFD3-2C04BE55C65BQ42144009-E0C00D35-4DB4-4333-8F36-14813CC9F27EQ42285550-66668A02-5DC9-40AF-A894-2D56E79AC980Q48164127-96300542-16C4-468A-8207-8976D45DCE5DQ50053966-A9B8C0B1-64EC-4BEF-98CD-771F11BF48F6Q50224587-823B98CC-6F60-45C8-B50F-44C43E704B1FQ52763511-589E99B0-118E-43F5-9C57-1670265C0B7A
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CD73 promotes tumor growth and metastasis
@ast
CD73 promotes tumor growth and metastasis
@en
type
label
CD73 promotes tumor growth and metastasis
@ast
CD73 promotes tumor growth and metastasis
@en
prefLabel
CD73 promotes tumor growth and metastasis
@ast
CD73 promotes tumor growth and metastasis
@en
P2860
P356
P1433
P1476
CD73 promotes tumor growth and metastasis
@en
P2093
P2860
P356
10.4161/ONCI.1.1.18068
P577
2012-01-01T00:00:00Z